APX2039 is a brain-penetrant and orally active Gwt1 protein inhibitor. APX2039 inhibits an early step in fungal glycosylphosphatidylinositol anchor biosynthesis. APX2039 can be used for the research of cryptococcal meningitis and invasive mycosis caused by Talaromyces marneffei[1][2][3].
Molecular Weight:
362.36
Purity:
98.44
CAS Number:
[2342606-49-7]
Formula:
C20H15FN4O2
Target:
Fungal
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted